|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Proceeds from sales of loans held for sale | |||||
| Originations of loans held for sale | |||||
| Items not requiring (providing) cash | |||||
| Depreciation | |||||
| Amortization | |||||
| Compensation expense for stock option grants | |||||
| Provision for credit losses | |||||
| Provision (credit) for unfunded commitments | |||||
| Net gain on loan sales | |||||
| Loss (gain) on sale of premises and equipment | |||||
| Loss (gain) on sale/write-down of other real estate and repossessions | |||||
| Accretion of deferred income, premiums, discounts and other | |||||
| Loss on derivative interest rate products | |||||
| Net non-cash gain recorded on contract termination | |||||
| Deferred income taxes | |||||
| Changes in | |||||
| Interest receivable | |||||
| Prepaid expenses and other assets | |||||
| Accrued expenses and other liabilities | |||||
| Income taxes refundable/payable | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Net change in loans | |||||
| Purchase of loans | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sale of other real estate and repossessions | |||||
| Proceeds from sale of available-for-sale securities | |||||
| Proceeds from repayments of held-to-maturity securities | |||||
| Proceeds from maturities, calls and repayments of available-for-sale securities | |||||
| Purchase of available-for-sale securities | |||||
| Investment in tax credit partnerships | |||||
| Redemption (purchase) of Federal Home Loan Bank stock and other interest-earning assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Net decrease in certificates of deposit | |||||
| Net increase (decrease) in checking and savings accounts | |||||
| Net increase (decrease) in brokered deposits | |||||
| Net increase (decrease) in short-term borrowings and other interest-bearing liabilities | |||||
| Proceeds from borrowing under Federal Reserve Bank Term Funding Program | |||||
| Repayment of borrowing under Federal Reserve Bank Term Funding Program | |||||
| Redemption of subordinated notes | |||||
| Advances from (to) borrowers for taxes and insurance | |||||
| Repurchase of the Company's common stock | |||||
| Dividends paid | |||||
| Stock options exercised | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning of Year | |||||
| Cash and Cash Equivalents, End of Year | |||||
Loading...